Most important cardiotoxicity of immune checkpoint inhibitors – Cardiology MCQ
Most important cardiotoxicity of immune checkpoint inhibitors – Cardiology MCQ
Interactive Kindle Edition: Check here for more Cardiology MCQs!
Immune checkpoint inhibitors are novel anti cancer drugs targeting immune checkpoint molecules: cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), programmed cell death 1 (PD-1) and its ligand (PD-L1) [1]. They are highly useful in a large number of solid and hematological tumours. The most important recently highlighted cardiovascular adverse effect of immune checkpoint inhibitors is:
Fulminant myocarditis
Acute myocardial infarction
QT prolongation
Venous thromboembolism
Post your answer as a comment below.
Correct answer will be published on: Mar 25, 2018 @ 06:57
Reference
Varricchi G, Galdiero MR, Marone G, Criscuolo G, Triassi M, Bonaduce D, Marone G, Tocchetti CG. Cardiotoxicity of immune checkpoint inhibitors. ESMO Open. 2017 Oct 26;2(4):e000247.
The post Most important cardiotoxicity of immune checkpoint inhibitors – Cardiology MCQ appeared first on Cardiophile MD.
Source: Cardiophile MD - Category: Cardiology Authors: Prof. Dr. Johnson Francis, MD, DM, FACC, FRCP Edin, FRCP London Tags: Cardiology MCQ DM / DNB Cardiology Entrance Source Type: blogs
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Heart | Heart Attack | Hematology | Myocarditis | Thrombosis